Filing Details

Accession Number:
0001628280-19-010910
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-16 20:31:45
Reporting Period:
2019-08-14
Accepted Time:
2019-08-16 20:31:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576280 Guardant Health Inc. GH Services-Medical Laboratories (8071) 454139254
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753789 J Michael Wiley 505 Penobscot Drive
Redwood City CA 94063
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-05 40,000 $0.00 231,737 No 5 G Direct
Common Stock Acquisiton 2019-08-05 10,000 $0.00 10,000 No 5 G Indirect Isabella Wiley 2019 Irrevocable Trust
Common Stock Acquisiton 2019-08-05 10,000 $0.00 10,000 No 5 G Indirect Andrew Wiley 2019 Irrevocable Trust
Common Stock Acquisiton 2019-08-05 10,000 $0.00 10,000 No 5 G Indirect Coleman Wiley 2019 Irrevocable Trust
Common Stock Acquisiton 2019-08-05 10,000 $0.00 10,000 No 5 G Indirect Matthew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 2,357 $97.88 7,643 No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 2,977 $98.75 4,666 No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 1,139 $99.68 3,527 No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 287 $100.75 3,240 No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 2,357 $97.88 7,643 No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 2,976 $98.75 4,667 No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 1,139 $99.68 3,528 No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 287 $100.75 3,241 No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 2,357 $97.88 7,643 No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 2,976 $98.75 4,667 No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 1,139 $99.68 3,528 No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 287 $100.75 3,241 No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 2,357 $97.88 7,643 No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 2,977 $98.75 4,666 No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 1,139 $99.68 3,527 No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-14 287 $100.75 3,240 No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-15 2,076 $97.93 1,164 No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-15 1,164 $98.51 0 No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-15 2,077 $97.93 1,164 No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-15 1,164 $98.51 0 No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-15 2,077 $97.93 1,164 No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-15 1,164 $98.51 0 No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-15 2,076 $97.93 1,164 No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
Common Stock Disposition 2019-08-15 1,164 $98.51 0 No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Indirect Isabella Wiley 2019 Irrevocable Trust
No 5 G Indirect Andrew Wiley 2019 Irrevocable Trust
No 5 G Indirect Coleman Wiley 2019 Irrevocable Trust
No 5 G Indirect Matthew Wiley 2019 Irrevocable Trust
No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
No 4 S Indirect Isabella Wiley 2019 Irrevocable Trust
No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
No 4 S Indirect Andrew Wiley 2019 Irrevocable Trust
No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
No 4 S Indirect Coleman Wiley 2019 Irrevocable Trust
No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
No 4 S Indirect Matthew Wiley 2019 Irrevocable Trust
Footnotes
  1. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, if any.
  2. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.23 to $98.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.23 to $99.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.44 to $100.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.57 to $101.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.24 to $98.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.25 to $99.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.